WebMar 27, 2024 · CytomX received a $30 million upfront payment in December 2024 and is eligible for up to approximately $2 billion in research, development, regulatory and sales … WebAug 6, 2024 · CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q2 2024 Results - Earnings Call Transcript Aug. 05, 2024 8:40 PM ET CytomX Therapeutics, Inc. (CTMX) SA Transcripts 133.18K Follower s Q2:...
Investor Relations CytomX Therapeutics, Inc.
WebCytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program South San Francisco, CA -May 13, 2024 - CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage ... VP, Investor Relations and Corporate Communications [email protected] 650-383-0823 . … WebMr. Ogden joined CytomX in August of 2024 after a 16-year tenure at Eli Lilly and Company where he held senior financial leadership positions including most recently as chief financial officer of Lilly Diabetes. Prior to his role in Lilly Diabetes, Mr. Ogden was the chief financial officer and treasurer of Lilly del Caribe in Puerto Rico. granbury pirate flag
Home - CytomX
WebMar 27, 2024 · On March 27, 2024, CytomX Therapeutics, Inc. filed an amended 2024 Annual Report on Form 10-K/A which included restated financial statements for the years ended December 31, 2024, 2024, and 2024 and the quarterly periods for 2024 and 2024. CytomX’s 2024 Annual Report on Form 10-K includes restated interim information for … WebCytomX embraces and acknowledges the importance of diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves and feel involved, respected, and connected. CytomX believes that we benefit from each other’s ideas and experiences. WebApr 29, 2024 · SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of ... granbury pirates